Covered recipient · General Payments record
NEIL KAPLOWITZ
General Payments · PY2018–2024
$111,312.50
- Reported across 81 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $34,350.00 | 24 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| AstraZeneca UK Limited | $34,350.00 | 24 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (24)
Sorted by paying entity, then date · as published by CMS
Program year 2024 20182019202020212023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AstraZeneca UK Limited | $1,012.50 | 04/05/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1110532820 | CMS |
| AstraZeneca UK Limited | $300.00 | 04/05/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1110534036 | CMS |
| AstraZeneca UK Limited | $300.00 | 04/05/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1110536286 | CMS |
| AstraZeneca UK Limited | $300.00 | 04/05/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1110537218 | CMS |
| AstraZeneca UK Limited | $1,012.50 | 04/05/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1110537359 | CMS |
| AstraZeneca UK Limited | $1,012.50 | 04/05/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1110538845 | CMS |
| AstraZeneca UK Limited | $300.00 | 04/05/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1110541127 | CMS |
| AstraZeneca UK Limited | $300.00 | 04/05/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1110543939 | CMS |
| AstraZeneca UK Limited | $300.00 | 04/05/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1110544151 | CMS |
| AstraZeneca UK Limited | $1,012.50 | 04/05/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1110547958 | CMS |
| AstraZeneca UK Limited | $1,012.50 | 04/05/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1110549696 | CMS |
| AstraZeneca UK Limited | $1,012.50 | 04/05/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1110550518 | CMS |
| AstraZeneca UK Limited | $1,012.50 | 04/05/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1110551672 | CMS |
| AstraZeneca UK Limited | $1,012.50 | 04/05/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1110553784 | CMS |
| AstraZeneca UK Limited | $300.00 | 04/05/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1110554486 | CMS |
| AstraZeneca UK Limited | $300.00 | 04/05/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1110555676 | CMS |
| AstraZeneca UK Limited | $1,050.00 | 05/17/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1110533230 | CMS |
| AstraZeneca UK Limited | $1,050.00 | 05/17/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1110543259 | CMS |
| AstraZeneca UK Limited | $1,050.00 | 05/17/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1110550004 | CMS |
| AstraZeneca UK Limited | $1,050.00 | 05/17/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1110552780 | CMS |
| AstraZeneca UK Limited | $1,050.00 | 05/17/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1110554168 | CMS |
| AstraZeneca UK Limited | $5,100.00 | 08/02/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1110548778 | CMS |
| AstraZeneca UK Limited | $6,900.00 | 08/16/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1110551332 | CMS |
| AstraZeneca UK Limited | $6,600.00 | 12/06/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1110542015 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.